EP. 1: Eileen M. O'Reilly, MD: How the Treatment Course Aligns With New NCCN GuidelinesSeptember 9th 2016
EP. 3: Eileen M. O'Reilly, MD: The Nab-Paclitaxel/Gemcitabine Regimen in Frontline Standard of CareSeptember 9th 2016
EP. 4: George P. Kim, MD: The Nab-Paclitaxel/Gemcitabine Regimen in Frontline Standard of CareSeptember 9th 2016
EP. 5: Eileen M. O'Reilly, MD: The Significance of Second-Line Therapy in Pancreatic CancerSeptember 9th 2016
EP. 6: George P. Kim, MD: The Significance of Second-Line Therapy in Pancreatic CancerSeptember 9th 2016
EP. 7: Eileen M. O'Reilly, MD: The Evolution of Therapy Sequencing Strategies in Pancreatic CancerSeptember 9th 2016
EP. 8: George P. Kim, MD: The Evolution of Therapy Sequencing Strategies in Pancreatic CancerSeptember 9th 2016
EP. 9: Eileen M. O'Reilly, MD: Diagnosing Patients With Pancreatic Cancer at an Earlier StageSeptember 9th 2016
EP. 10: George P. Kim, MD: Diagnosing Patients With Pancreatic Cancer at an Earlier StageSeptember 9th 2016
